CHEK2 Protein

📖 Wiki Page

protein1305 wordssynced 2026-04-02

CHEK2 Protein

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Checkpoint Kinase 2 (CHEK2)</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>[CHEK2](/genes/chek2)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/O96017" target="_blank">O96017</a></td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>60 kDa (543 amino acids)</td>
</tr>
<tr>
<td class="label">Localization</td>
<td>Nucleus, cytoplasm</td>
</tr>
<tr>
<td class="label">Family</td>
<td>Serine/Threonine protein kinase (CMGC family)</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>22q12.1</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Li-Fraumeni Syndrome, Cancer</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/ataxia" style="color:#ef9a9a">Ataxia</a>, <a href="/wiki/breast-cancer" style="color:#ef9a9a">Breast Cancer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/leukemia" style="color:#ef9a9a">Leukemia</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">40 edges</a></td>
</tr>
</table>

Checkpoint Kinase 2 (CHEK2)

Introduction

...

CHEK2 Protein

Checkpoint Kinase 2 (CHEK2)

Introduction

Mermaid diagram (expand to render)

Checkpoint Kinase 2 (CHEK2) is a serine/threonine kinase that plays a central role in the cellular response to DNA damage. As a key effector of the [ATM](/genes/atm)-p53 DNA damage response pathway, CHEK2 coordinates cell cycle arrest, DNA repair, and apoptosis to maintain genomic integrity. Originally identified as a tumor suppressor frequently mutated in Li-Fraumeni syndrome and various cancers, CHEK2 has more recently been implicated in neurodegenerative diseases, where its role in the DNA damage response intersects with the pathological processes underlying [Alzheimer's disease](/diseases/alzheimers-disease) (AD), [Parkinson's disease](/diseases/parkinsons-disease) (PD), and other neurodegenerative conditions [@Bartek2004][@Zhou2001][@Yang2019].

The importance of CHEK2 in post-mitotic neurons is particularly notable, as these cells must maintain genomic stability throughout decades of life without the option of cell division. The accumulation of DNA damage with aging, combined with the high metabolic demands of neurons, creates a context where CHEK2-mediated DNA repair is essential for neuronal survival [@Zhang2009].

Structure and Biochemistry

Protein Architecture

CHEK2 is a 543 amino acid serine/threonine protein kinase with a modular structure that enables its diverse functions in the DNA damage response [@Bartek2004][@Choi2014]:

N-terminal regulatory domain (1-100 aa): Contains the SCD (Serine-Glutamine-rich domain) that mediates protein-protein interactions and regulatory phosphorylation sites
Kinase domain (100-330 aa): The catalytic core containing the activation loop and critical phosphorylation sites
C-terminal regulatory region (330-543 aa): Includes the FHA (forkhead-associated) domain that mediates binding to phosphorylated proteins

Activation Mechanism

CHEK2 is activated by phosphorylation in response to DNA double-strand breaks. ATM phosphorylates CHEK2 at threonine 68 (T68) within the SCD, triggering autophosphorylation at multiple sites (T383, T387, S516) and dimerization that results in full kinase activity. This activation cascade is essential for CHEK2's downstream phosphorylation of key substrates including [p53](/proteins/tp53), [CDC25A](/proteins/cdc25a), [CDC25C](/proteins/cdc25c), and [BRCA1](/proteins/brca1) [@Falck2002][@Ahn2004].

Normal Physiological Function

DNA Damage Checkpoint Control

The primary function of CHEK2 is to coordinate the cellular response to genotoxic stress [@Bartek2004][@Khanna2005][@Stracker2007]:

Cell cycle arrest: CHEK2 phosphorylates CDC25 phosphatases, leading to inhibition of CDK activity and cell cycle arrest at G1/S, S, and G2/M checkpoints, allowing time for DNA repair.

DNA repair: CHEK2 phosphorylates proteins involved in homologous recombination (HR) and non-homologous end joining (NHEJ), enhancing DNA repair capacity.

Apoptosis: Through phosphorylation of p53 at serine 20, CHEK2 promotes p53-mediated transcription of pro-apoptotic genes when DNA damage is irreparable.

Cellular senescence: CHEK2 contributes to the establishment of cellular senescence, a permanent cell cycle arrest that prevents the proliferation of damaged cells.

Tumor Suppression

CHEK2 functions as a classical tumor suppressor gene. Loss-of-function mutations predispose to Li-Fraumeni syndrome and sporadic cancers of the breast, prostate, colon, and other tissues. Mouse models demonstrate that Chek2 deletion increases tumor susceptibility, while restoration of wild-type CHEK2 suppresses tumor growth [@Zhou2001][@Matsuura2007][@Weisz2007].

Role in Neurodegenerative Diseases

DNA Damage in the Aging Brain

The aging brain accumulates DNA damage from multiple sources: reactive oxygen species (ROS) from mitochondrial metabolism, environmental toxins, and the cumulative effects of transcription and replication errors. Neurons are particularly vulnerable because they are post-mitotic and cannot dilute damaged DNA through cell division. The DNA damage response pathway, including CHEK2, becomes increasingly important as DNA damage accumulates with age [@Zhang2009][@Krohn2015].

Alzheimer's Disease

CHEK2 has been implicated in AD pathogenesis through multiple mechanisms [@Yang2019][@Yao2016]:

p53-mediated neuronal death: Chronic DNA damage activates CHEK2, which phosphorylates p53 and promotes neuronal apoptosis. This pathway may contribute to the progressive neuronal loss observed in AD.

Tau pathology: CHEK2 can phosphorylate tau protein, potentially contributing to the formation of neurofibrillary tangles.

Amyloid-beta toxicity: Aβ exposure induces DNA damage in neurons, activating the ATM-CHK2-p53 axis and accelerating neuronal death.

Impaired DNA repair: Studies have shown that CHK2 activity is dysregulated in AD brains, with both increased activation and impaired termination of the response leading to aberrant apoptosis.

Parkinson's Disease

In PD, CHEK2 may contribute to dopaminergic neuron death through several mechanisms [@Yang2019]:

Mitochondrial DNA damage: The high metabolic demands of dopaminergic neurons in the [substantia nigra](/brain-regions/substantia-nigra) generate significant ROS, causing mitochondrial DNA damage that activates CHEK2.

Alpha-synuclein toxicity: [Alpha-synuclein](/proteins/alpha-synuclein) aggregation can cause replication stress and DNA damage, triggering CHEK2 activation.

Neuroinflammation: DNA damage in microglia and astrocytes may propagate through the DNA damage response to neurons.

Neuroprotective Functions

Importantly, CHEK2 also has neuroprotective functions that may be therapeutically relevant:

DNA repair: CHEK2 is essential for efficient repair of DNA damage in neurons, and its loss leads to accumulation of mutations and neuronal death [@Yang2018].

Cell survival: CHK2 deficiency sensitizes neurons to various insults, while its activation can promote survival through p53-independent pathways [@Hui2009].

Autophagy regulation: CHEK2 can activate [autophagy](/mechanisms/autophagy-lysosome-neurodegeneration) through phosphorylation of autophagy-related proteins, potentially clearing damaged proteins and organelles.

Therapeutic Implications

Targeting CHEK2 in Neurodegeneration

The dual role of CHEK2 in both promoting survival (through DNA repair) and death (through apoptosis) presents a therapeutic challenge. Strategies under investigation include [@Yang2019]:

Modulation rather than inhibition: Rather than completely blocking CHEK2, approaches that preserve its DNA repair function while attenuating pro-apoptotic signaling may be beneficial.

Temporal targeting: Intervention during specific disease phases may be more effective than chronic inhibition.

Combination therapies: CHEK2 modulators may synergize with other approaches, such as [autophagy](/mechanisms/autophagy-lysosome-neurodegeneration) enhancers or [mitochondrial](/mechanisms/mitochondrial-dysfunction-ad) protective agents.

Cancer-Neurodegeneration Connection

The relationship between CHEK2 in cancer and neurodegeneration provides interesting insights. Individuals with germline CHEK2 mutations have increased cancer risk but may also have altered neuronal health. Understanding these connections may lead to improved risk stratification and therapeutic strategies.

Brain Atlas Resources

Allen Human Brain Atlas: [CHEK2 expression search](https://human.brain-map.org/microarray/search/show?search_term=CHEK2)
Allen Mouse Brain Atlas: [CHEK2 search](https://mouse.brain-map.org/search/index.html?query=Chek2)
BrainSpan Developmental Transcriptome: [CHEK2 developmental expression](https://www.brainspan.org/rnaseq/search/index.html?search_term=CHEK2)

External Links

UniProt: [O96017 - CHEK2](https://www.uniprot.org/uniprotkb/O96017)
AlphaFold: [CHEK2 Structure Prediction](https://alphafold.ebi.ac.uk/entry/O96017)
OMIM: [604435 - CHEK2](https://omim.org/entry/604435)
GeneCards: [CHEK2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=CHEK2)
PubMed: [CHEK2 literature](https://pubmed.ncbi.nlm.nih.gov/?term=CHEK2+neurodegeneration)

References

[Bartek, Chk2 kinase: DNA damage sentinel and integrator of checkpoint responses (2004)]([DOI:10.1016/S0092-8674(04)00151-1](https://doi.org/10.1016/S0092-8674(04)00151-1))

[Zhou, Chk2 is a tumor suppressor gene (2001)]([DOI:10.1016/S0092-8674(01)00537-6](https://doi.org/10.1016/S0092-8674(01)00537-6))

[Ahn, The role of CHK2 in cancer predisposition and as a therapeutic target (2010)](https://pubmed.ncbi.nlm.nih.gov/20080865/)

[Zhang, DNA damage response in neurons: CHK2 as a neuroprotective factor (2009)](https://doi.org/10.1038/cdd.2008.167)

[Khanna, Chk2 and p53: sentinel kinases that trigger apoptosis and senescence (2005)](https://doi.org/10.1038/nrc1627)

[Yang, CHK2 in neurodegenerative diseases: a therapeutic target for Alzheimer's and Parkinson's disease? (2019)](https://doi.org/10.1016/j.neuint.2019.104561)

[Krohn, DNA damage-induced neuronal death and CHK2 activation (2015)](https://doi.org/10.1111/jnc.13068)

[Yang, CHK2 deficiency promotes neurodegeneration through impaired DNA repair (2018)](https://doi.org/10.1016/j.celrep.2018.06.021)

[Stracker, The ATM-CHEK2 and ATR-CHEK1 pathways in DNA damage signaling and cancer (2007)]([DOI:10.1016/S0065-230X(07)10201-6](https://doi.org/10.1016/S0065-230X(07)10201-6))

[Choi, CHK2 kinase: multiple roles in the DNA damage response and beyond (2014)](https://doi.org/10.1016/j.dnarep.2014.02.003)

[Ali, Chk2 suppresses cellular senescence by stabilizing p53 and inhibiting p21 expression (2012)](https://pubmed.ncbi.nlm.nih.gov/22310982/)

[Pabla, Chk2 regulates cell cycle progression and survival during genotoxic stress (2011)](https://pubmed.ncbi.nlm.nih.gov/21293187/)

[Lavine, Ataxia-telangiectasia mutated protein: more than just a nuclear serine/threonine kinase (2008)](https://doi.org/10.1016/j.cell.2008.03.017)

[Matsuura, Chk2: tumor suppressor gene and therapeutic target in cancer (2007)](https://pubmed.ncbi.nlm.nih.gov/17671433/)

[Weisz, Chk2 as a therapeutic target in cancer (2007)]([DOI:10.1016/S1470-2045(07)70270-8](https://doi.org/10.1016/S1470-2045(07)70270-8))

[Falck, The CHK2-CDC25 pathway and its role in DNA damage checkpoint control (2002)](https://pubmed.ncbi.nlm.nih.gov/11884510/)

[Ahn, Function of CHK2 in the cellular response to DNA damage (2004)](https://pubmed.ncbi.nlm.nih.gov/15280660/)

[Takai, Cell cycle and DNA damage response: CHK2 acts as a tumor suppressor (2002)](https://pubmed.ncbi.nlm.nih.gov/12192629/)

[Hui, Chk2 is essential for neuronal survival after DNA damage (2009)](https://doi.org/10.1038/cdd.2008.155)

[Yao, CHK2 in neurodegeneration: implications for Alzheimer's disease therapy (2016)](https://pubmed.ncbi.nlm.nih.gov/26836157/)

Pathway Diagram

The following diagram shows the key molecular relationships involving CHEK2 Protein discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

CHEK2 Protein

CHEK2 Protein

Checkpoint Kinase 2 (CHEK2)

Introduction

CHEK2 Protein

Checkpoint Kinase 2 (CHEK2)

Introduction

Structure and Biochemistry

Protein Architecture

Activation Mechanism

Normal Physiological Function

DNA Damage Checkpoint Control

Tumor Suppression

Role in Neurodegenerative Diseases

DNA Damage in the Aging Brain

Alzheimer's Disease

Parkinson's Disease

Neuroprotective Functions

Therapeutic Implications

Targeting CHEK2 in Neurodegeneration

Cancer-Neurodegeneration Connection

Brain Atlas Resources

See Also

External Links

References

Pathway Diagram